Promoting the intelligentization of pharmaceutical equipment has become a new hot spot in the pharmaceutical machine industry

[Pharmaceutical Network Market Analysis] According to data, from 2016 to 2020, the compound annual growth rate of the market size of China's pharmaceutical equipment industry will remain at about 20%, and the industry market size in 2020 will be about 130 billion yuan
.

According to Guosen Securities, the domestic pharmaceutical equipment market is expected to reach 174 billion yuan by 2024
.

 Promoting the intelligentization of pharmaceutical equipment has become a new hot spot in the pharmaceutical machine industry (Source: Pharmaceutical Network) With the continuous expansion of the pharmaceutical equipment market, it should be noted that pharmaceutical equipment companies have begun to accelerate the pace of transformation and upgrading
.

According to the author's understanding, in recent years, under the new situation of the continuous development of the pharmaceutical industry and the accelerated technological change, more and more pharmaceutical equipment companies have vigorously developed in the direction of "unmanned, less humanized, and intelligent"
.

In this context, the trend of intelligence has gradually become the long-term direction of the development of pharmaceutical equipment enterprises
.

Pharmaceutical equipment is an important means of pharmaceutical production, which represents the level of production in the pharmaceutical industry and affects the improvement of drug quality
.

Therefore, the industry generally believes that under the accelerated upgrading of the current pharmaceutical equipment industry, its intelligence will also be more and more valued by pharmaceutical companies
.

At the same time, China's pharmaceutical equipment industry will also move towards intelligence in an all-round way, including product intelligence, manufacturing intelligence, service intelligence, management intelligence and life intelligence
.

 　　In fact, many companies are already on the road of intelligent product development
.

It is understood that under the general trend of intelligent manufacturing in recent years, related enterprises have developed a lot of intelligent pharmaceutical equipment.
In addition, many enterprises have added digitalization and intelligence to the strategy of enterprise layout.
in the list
.

 　　For example, in recent years, Chutian Technology has realized a new mode of robot manufacturing by making full use of Internet technology, Internet of Things technology, automated logistics system and other technologies, using industrial robots to produce medical robots
.

And through acquisitions and other means to accelerate the layout to build a "smart and smart pharmaceutical factory", making sufficient preparations for entering the "pharmaceutical industry 4.
0 era"
.

In the future, it will also develop towards intelligence and platform to provide global customers with overall technical solutions
.

The company's growth path will revolve around the strategy of "one vertical, one horizontal and one platform" and the development of Industry 4.
0 and intelligent manufacturing.
To this end, it is necessary to build the enterprise's technological innovation capabilities, manufacturing innovation capabilities, market expansion capabilities, and basic operational capabilities.
Support the realization of the company's strategy and business objectives
.

 　　In addition, Canaan Technology also plans to build a two-way "Future Factory" from the aspects of digital twin technology, intelligent production, digital management, networked collaboration, and personalized customization.
In the future, it will form intelligent and whole-line engineering design capabilities.
Provide more high value-added services
.

 　　It is worth mentioning that with the development of intelligent manufacturing, more and more pharmaceutical equipment companies are accelerating the transformation from "manufacturing" to "intelligent manufacturing", striving to realize the automation of the entire workshop
.

Among them, Tofflon is one of the representatives.
At the end of 2020, Tofflon announced an investment of 500 million yuan to build a biopharmaceutical system equipment industrialization project.
According to the investment plan, the first phase of the project is planned to be put into production in 3 years, and achieve production in 5 years.
, the annual output value is more than 500 million yuan
.

After the project is put into production, it will help to expand the company's biological equipment manufacturing capacity
.

 　　Compared with traditional pharmaceutical equipment enterprises, pharmaceutical equipment enterprises that integrate intelligent technology can accurately "take the pulse" for the enterprise through effective information management, find out the mistakes and make improvements in time, thereby improving the production and operation efficiency of the enterprise and reducing the cost of the enterprise.
cost
.

Therefore, it is expected that more and more local pharmaceutical machine companies will continue to increase investment in research and development, strive to break the import monopoly, and launch new products and new technologies to boost the pace of import substitution of domestically produced intelligent pharmaceutical equipment
.

 　　Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.